{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:49:51Z","timestamp":1788871791209,"version":"build-2803163510"},"reference-count":48,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"European Community's Seventh Framework Program","award":["FP7\/2007-2013"],"award-info":[{"award-number":["FP7\/2007-2013"]}]},{"name":"Cosmetics Europe through the COSMOS project","award":["266835"],"award-info":[{"award-number":["266835"]}]},{"name":"French ministry of ecology"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxicology Letters"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.toxlet.2013.03.032","type":"journal-article","created":{"date-parts":[[2013,4,6]],"date-time":"2013-04-06T11:02:26Z","timestamp":1365246146000},"page":"26-34","source":"Crossref","is-referenced-by-count":31,"title":["Prediction of dose-hepatotoxic response in humans based on toxicokinetic\/toxicodynamic modeling with or without in vivo data: A case study with acetaminophen"],"prefix":"10.1016","volume":"220","author":[{"given":"Alexandre R.R.","family":"P\u00e9ry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Brochot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence A.","family":"Zeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Mombelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Desmots","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Pavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Fioravanzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9-Manuel","family":"Zald\u00edvar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxlet.2013.03.032_bib0005","unstructured":"ACD\/PhysChem Suite, version 12.00. Advanced Chemistry Development, Inc., Toronto, ON, Canada. www.acdlabs.com, 2012."},{"key":"10.1016\/j.toxlet.2013.03.032_bib0010","unstructured":"ACD\/ADME Suite, version 5.0. Advanced Chemistry Development, Inc., Toronto, ON, Canada. www.acdlabs.com, 2012."},{"key":"10.1016\/j.toxlet.2013.03.032_bib0015","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00204-011-0693-2","article-title":"Alternative (non-animal) methods for cosmetics testing: current status and future prospects-2010","volume":"85","author":"Adler","year":"2011","journal-title":"Archives of Toxicology"},{"key":"10.1016\/j.toxlet.2013.03.032_bib0020","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/toxsci\/kfq188","article-title":"The vision of toxicity testing in the 21st century: moving from discussion to action","volume":"117","author":"Andersen","year":"2010","journal-title":"Toxicological Sciences"},{"key":"10.1016\/j.toxlet.2013.03.032_bib0025","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/00007691-200402000-00009","article-title":"The binding of selected therapeutic drugs to human serum [alpha]-1 acid glycoprotein and to human serum albumin in vitro","volume":"26","author":"Bailey","year":"2004","journal-title":"Therapeutic Drug Monitoring"},{"key":"10.1016\/j.toxlet.2013.03.032_bib0030","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1093\/clinchem\/30.10.1631","article-title":"Urinary excretion of acetaminophen andits metabolites as studied by proton NMR spectroscopy","volume":"30","author":"Bales","year":"1984","journal-title":"Clinical Chemistry"},{"key":"10.1016\/j.toxlet.2013.03.032_bib0035","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2174\/138920007779315053","article-title":"Scaling factors for the extrapolation of in vivo metabolic drug clearance from in vitro data: reaching a consensus on values of human microsomal protein and hepatocellularity per gram of liver","volume":"8","author":"Barter","year":"2007","journal-title":"Current Drug Metabolism"},{"key":"10.1016\/j.toxlet.2013.03.032_bib0040","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0272-6386(96)90561-2","article-title":"Acetaminophen: acute and chronic effects on renal function","volume":"28","author":"Blantz","year":"1996","journal-title":"American Journal of Kidney Diseases"},{"issue":"9","key":"10.1016\/j.toxlet.2013.03.032_bib0045","doi-asserted-by":"crossref","DOI":"10.18637\/jss.v002.i09","article-title":"MCSim: a simulation program","volume":"2","author":"Bois","year":"1997","journal-title":"Journal of Statistical Software"},{"key":"10.1016\/j.toxlet.2013.03.032_bib0050","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1079\/BJN19790060","article-title":"The effect of wheat bran and pectin on paracetamol absorption in the rat","volume":"41","author":"Brown","year":"1979","journal-title":"British Journal of Nutrition"},{"key":"10.1016\/j.toxlet.2013.03.032_bib0055","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S1367-5931(00)00228-3","article-title":"Prediction of pharmacokinetic properties using experimental approaches during early drug discovery","volume":"5","author":"Chaturvedi","year":"2001","journal-title":"Current Opinion in Chemical Biology"},{"key":"10.1016\/j.toxlet.2013.03.032_bib0060","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/nature04648","article-title":"Pharmaco-metabonomic phenotyping and personalized drug treatment","volume":"440","author":"Clayton","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.toxlet.2013.03.032_bib0065","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.taap.2008.04.021","article-title":"Quantitative interpretation of human biomonitoring data","volume":"231","author":"Clewell","year":"2008","journal-title":"Toxicology and Applied Pharmacology"},{"key":"10.1016\/j.toxlet.2013.03.032_bib0070","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1365-2710.2004.00626.x","article-title":"Differences in the single-oral-dose pharmacokinetics and urinary excretion of paracetamol and its conjugates between Hong-Kong Chinese and Caucasian subjects","volume":"30","author":"Critchley","year":"2005","journal-title":"Journal of Clinical Pharmacy and Therapeutics"},{"key":"10.1016\/j.toxlet.2013.03.032_bib0075","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1023\/A:1018943613122","article-title":"Physiological parameters in laboratory animals and humans","volume":"10","author":"Davies","year":"1993","journal-title":"Pharmaceutical Research"},{"key":"10.1016\/j.toxlet.2013.03.032_bib0080","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.tiv.2012.01.009","article-title":"Implementation challenges for designing integrated in vitro testing strategies (ITS) aiming at reducing and replacing animal experimentation","volume":"26","author":"De Wever","year":"2012","journal-title":"Toxicology in vitro"},{"key":"10.1016\/j.toxlet.2013.03.032_bib0085","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.2165\/00003088-200645100-00005","article-title":"Development and evaluation of a generic physiologically based pharmacokinetic model for children","volume":"45","author":"Edginton","year":"2006","journal-title":"Clinical Pharmacokinetics"},{"key":"10.1016\/j.toxlet.2013.03.032_bib0090","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/BF03189719","article-title":"Paracetamol metabolism in two ethnically different Spanish populations","volume":"21","author":"Esteban","year":"1996","journal-title":"European Journal of Drug Metabolism and Pharmacokinetics"},{"key":"10.1016\/j.toxlet.2013.03.032_bib0095","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/toxsci\/kfs122","article-title":"Determination of drug toxicity using 3D spheroids constructed from an immortal human hepatocyte cell line","volume":"127","author":"Fey","year":"2012","journal-title":"Toxicological Sciences"},{"key":"10.1016\/j.toxlet.2013.03.032_bib0100","first-page":"14","article-title":"Dose and time-dependent elimination of acetaminophen in rats: pharmacokinetic implications of cosubstrate depletion","volume":"219","author":"Galinsky","year":"1981","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.toxlet.2013.03.032_bib0105","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.yrtph.2005.05.002","article-title":"An alternative approach for the safety evaluation of new and existing chemicals an exercise in integrated testing","volume":"42","author":"Gubbels-van Hal","year":"2005","journal-title":"Regulatory Toxicology and Pharmacology"},{"key":"10.1016\/j.toxlet.2013.03.032_bib0250","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S1382-6689(98)00008-8","article-title":"Physiologically-based pharmacokinetic modeling of pyrene in the rat","volume":"5","author":"Haddad","year":"1998","journal-title":"Environmental Toxicology and Pharmacology"},{"key":"10.1016\/j.toxlet.2013.03.032_bib0110","first-page":"407","article-title":"Glucuronidation and biliary excretion of acetaminophen in rats","volume":"228","author":"Hjelle","year":"1984","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.toxlet.2013.03.032_bib0115","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1080\/00498250210123094","article-title":"Pharmacokinetic analysis of factors determining elimination pathways for sulfate and glucuronide metabolites of drugs. I. Studies by in vivo constant infusion","volume":"32","author":"Ishii","year":"2002","journal-title":"Xenobiotica"},{"key":"10.1016\/j.toxlet.2013.03.032_bib0120","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.lfs.2011.01.025","article-title":"Current issues with acetaminophen hepatotoxicity \u2013 a clinical relevant model to test the efficacy of natural products","volume":"88","author":"Jaeschke","year":"2011","journal-title":"Life Sciences"},{"key":"10.1016\/j.toxlet.2013.03.032_bib0125","first-page":"1015","article-title":"Homeostasis of sulfate and 3\u2032-phosphoadenosine 5\u2032-phosphosulfate in rats after acetaminophen administration","volume":"261","author":"Kim","year":"1992","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.toxlet.2013.03.032_bib0130","series-title":"The Analysis of Aquatic Toxicity Data","author":"Kooijman","year":"1996"},{"key":"10.1016\/j.toxlet.2013.03.032_bib0135","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/10937404.2010.483176","article-title":"Toxicity testing in the 21st century: a vision and a strategy","volume":"13","author":"Krewski","year":"2010","journal-title":"Journal of Toxicology and Environmental Health Part B: Critical Reviews"},{"key":"10.1016\/j.toxlet.2013.03.032_bib0145","first-page":"1008","article-title":"Species similarities and differences in pharmacokinetics","volume":"23","author":"Lin","year":"1995","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.toxlet.2013.03.032_bib0150","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1006\/taap.1996.0151","article-title":"Different mechanism of saturation of acetaminophen sulfate conjugation in mice and rats","volume":"139","author":"Liu","year":"1996","journal-title":"Toxicology and Applied Pharmacology"},{"key":"10.1016\/j.toxlet.2013.03.032_bib0155","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1517\/17425255.2012.639762","article-title":"Toward in vitro biomarkers for developmental toxicity and their extrapolation to the in vivo situation","volume":"8","author":"Louisse","year":"2012","journal-title":"Expert Opinion on Drug Metabolism and Toxicology"},{"key":"10.1016\/j.toxlet.2013.03.032_bib0160","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1002\/hep.24132","article-title":"HepaRG cell: a human model to study mechanisms of acetaminophen hepatotoxicity","volume":"53","author":"McGill","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.toxlet.2013.03.032_bib0165","series-title":"Altex Proceedings, 1\/12, Proceedings of WC8","article-title":"Hepatotoxicity screening taking a mode-of-action approach using HepaRG Cells and HCA","author":"Mennecozzi","year":"2011"},{"key":"10.1016\/j.toxlet.2013.03.032_bib0170","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.toxlet.2009.06.861","article-title":"Bisphenol A levels in blood depend on age and exposure","volume":"190","author":"Mielke","year":"2009","journal-title":"Toxicology Letters"},{"key":"10.1016\/j.toxlet.2013.03.032_bib0180","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1124\/dmd.31.5.580","article-title":"Utility of hepatocytes in predicting drug metabolism: comparison of hepatic intrinsic clearance in rats and humans in vivo and in vitro","volume":"31","author":"Naritomi","year":"2003","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.toxlet.2013.03.032_bib0185","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ijpharm.2012.03.019","article-title":"Prediction of the human oral bioavailability by using in vitro and in silico drug related parameters in a physiologically based absorption model","volume":"429","author":"Paix\u00e3o","year":"2012","journal-title":"International Journal of Pharmaceutics"},{"key":"10.1016\/j.toxlet.2013.03.032_bib0190","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.toxlet.2010.11.017","article-title":"Predicting in vivo gene expression in macrophages after exposure to benzo(a)oyrene based on in vitro assays and toxicokinetic\/toxicodynamic models","volume":"201","author":"P\u00e9ry","year":"2011","journal-title":"Toxicology Letters"},{"key":"10.1016\/j.toxlet.2013.03.032_bib0195","first-page":"105","article-title":"Evaluation of research activities and research needs to increase the impact and applicability of alternative testing strategies in risk assessment practice","volume":"61","author":"Punt","year":"2011","journal-title":"Regulatory Toxicology and Pharmacology"},{"key":"10.1016\/j.toxlet.2013.03.032_bib0200","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/BF00607678","article-title":"Pharmacokinetics of paracetamol (acetaminophen) after intravenous and oral administration","volume":"11","author":"Rawlins","year":"1977","journal-title":"European Journal of Clinical Pharmacology"},{"key":"10.1016\/j.toxlet.2013.03.032_bib0205","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1080\/00498250902763440","article-title":"Assessment of cryopreserved human hepatocytes as a model system to investigate sulfation and glucuronidation and to evaluate inhibitors of drug conjugation","volume":"39","author":"Riches","year":"2009","journal-title":"Xenobiotica"},{"key":"10.1016\/j.toxlet.2013.03.032_bib0210","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1002\/jps.20502","article-title":"Physiologically based pharmacokinetic modeling 2: predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions","volume":"95","author":"Rodgers","year":"2006","journal-title":"Journal of Pharmacological Sciences"},{"key":"10.1016\/j.toxlet.2013.03.032_bib0255","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.tiv.2012.12.004","article-title":"Assessment of an automated in vitro basal cytotoxicity test system based on metabolically-competent cells","volume":"27","author":"Rodrigues","year":"2013","journal-title":"Toxicology In Vitro"},{"key":"10.1016\/j.toxlet.2013.03.032_bib0220","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/toxsci\/kfq220","article-title":"Incorporating human dosimetry and exposure into high-throughput in vitro toxicity screening","volume":"117","author":"Rotroff","year":"2010","journal-title":"Toxicological Sciences"},{"key":"10.1016\/j.toxlet.2013.03.032_bib0225","doi-asserted-by":"crossref","first-page":"419","DOI":"10.5414\/CPP40419","article-title":"Absorption kinetics of paracetamol are not influenced by high anxiety levels in preoperative patients","volume":"40","author":"Schwarz","year":"2002","journal-title":"International Journal of Clinical Pharmacy and Therapeutics"},{"key":"10.1016\/j.toxlet.2013.03.032_bib0230","doi-asserted-by":"crossref","DOI":"10.3109\/00498254.2012.669080","article-title":"Practical use of the regression offset approach for the prediction of in vivo intrinsic clearance from hepatocytes","author":"Sohlenius-Sternbeck","year":"2012","journal-title":"Xenobiotica"},{"key":"10.1016\/j.toxlet.2013.03.032_bib0235","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1124\/jpet.105.092916","article-title":"Improving the in vitro prediction of in vivo central nervous system penetration: integrating permeability, P-glycoprotein efflux, and free fractions in blood and brain","volume":"316","author":"Summerfield","year":"2006","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.toxlet.2013.03.032_bib0240","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/BF01061867","article-title":"Pharmacokinetic study of the fate of acetaminophen and its conjugates in rats","volume":"11","author":"Watari","year":"1983","journal-title":"Journal of Pharmacokinetics and Biopharmaceutics"},{"key":"10.1016\/j.toxlet.2013.03.032_bib0245","doi-asserted-by":"crossref","first-page":"633","DOI":"10.3109\/10408444.2012.692115","article-title":"Quantitative in vitro to in vivo extrapolation of cell-based toxicity assay results","volume":"42","author":"Yoon","year":"2012","journal-title":"Critical Reviews in Toxicology"}],"container-title":["Toxicology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037842741300146X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037842741300146X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,24]],"date-time":"2020-07-24T21:04:22Z","timestamp":1595624662000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S037842741300146X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S037842741300146X"],"URL":"https:\/\/doi.org\/10.1016\/j.toxlet.2013.03.032","relation":{},"ISSN":["0378-4274"],"issn-type":[{"value":"0378-4274","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}